文献速递母胎医学产科

产前外显子测序回顾性诊断率:ODYSSEY队列研究

Obtaining a Diagnostic Yield via Scan findings prior to the introduction of SEquencing retrospectivelY (ODYSSEY): a cohort study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2026-08-14

该研究回顾性分析北爱尔兰2010至2018年出生、出生后经二代测序确诊单基因病的101名儿童,对照现行英国产前外显子测序(PES)标准,发现17.8%可产前诊断,诊断历程中位3.7年,但58.4%产前无结构异常。

要点

  • 17.8%的单基因病儿童按现行PES标准可产前诊断,避免近4年诊断历程。
  • 58.4%的患儿产前未发现结构异常,19.8%为低危结构异常不符合PES标准。
  • 80.2%的患儿出生后表现为神经发育迟缓/智力障碍和/或行为异常。

核心结论

  • 近五分之一单基因病儿童按现行PES标准可产前诊断,避免近4年诊断历程。
  • 但超过半数患儿产前无结构异常,胎儿影像对排除遗传综合征的安慰作用有限。

研究设计与样本

  • 回顾性队列研究,纳入北爱尔兰2010年1月至2018年1月出生、出生后经二代测序确诊单基因病的101名儿童。
  • 临床数据回顾性对照现行英国国民健康服务体系PES方案,包括表型入选标准和相关胎儿异常基因panel。

主要发现

  • 17.8%(95%CI 10.3-25.3%)的患儿同时具备高危胎儿结构异常和panel内诊断基因,可产前诊断。
  • 该亚组诊断历程中位3.7年(1354天,范围822-2450天)。
  • 58.4%(n=59)产前未检出异常,19.8%(n=20)为低危胎儿结构异常不符合PES标准。
  • 低危胎儿结构异常患儿中89.9%(71/79)受严重或极重度综合征影响。
  • 80.2%(n=81)患儿出生后表现为神经发育迟缓/智力障碍和/或行为异常,其中80.2%(65/81)产前无符合PES标准的胎儿异常。

关键数值与推荐

  • PES表型入选标准:高危胎儿结构异常且诊断基因在相关胎儿异常基因panel上。
  • 低危胎儿结构异常不符合现行PES入选标准。

临床怎么用

  • 对高危胎儿结构异常且基因在panel内的病例,可考虑PES以缩短诊断历程。
  • 产前无结构异常不能排除单基因病,咨询时应告知胎儿影像的局限性。

局限性

  • 回顾性设计,样本来自北爱尔兰两个英国研究队列,结果外推需谨慎。
  • 仅评估现行PES方案下可诊断的比例,未评估实际检测性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the retrospective yield of prenatal exome sequencing (PES) by establishing the proportion of children with a postnatal monogenic diagnosis that could have been diagnosed prenatally if PES had been available. METHODS: The study cohort comprised a sample of children in Northern Ireland, born between January 2010 and January 2018 (predating routine availability of PES), who received a monogenic diagnosis postnatally via next generation sequencing as part of either of two UK-wide studies (the 100 000 Genomes Project (2015-2018) or the Deciphering Developmental Disorders study (2011-2015)). Clinical data were collected retrospectively and correlated with the current UK National Health Service PES protocol, including the phenotypic eligibility criteria for PES and the associated fetal anomalies gene panel. Cases were considered retrospective diagnoses if the fetal phenotype would have been eligible for PES and the diagnostic gene was included on the test panel, meaning prenatal diagnosis in this current era could have been feasible. RESULTS: Of 101 children, 17.8% (95% CI, 10.3-25.3%) had both an eligible fetal structural anomaly (FSA) (i.e. high-risk FSA) and a diagnostic gene on the associated test panel, meaning that they could have been diagnosed prenatally in the current clinical landscape. The median length of the diagnostic odyssey for this subgroup of children was 3.7 years (1354 (range, 822-2450) days). Moreover, 58.4% (n = 59) of cases had no anomalies detected prenatally and 19.8% (n = 20) had a FSA that would not meet the eligibility criteria for PES (low-risk FSA). Although these cases would have been ineligible for PES under the current clinical pathway, 89.9% (n = 71/79) were affected by severe or profound syndromes. Postnatally, the most common functional anomalies were neurodevelopmental delay/intellectual disability and/or behavioral abnormality, which were observed in 80.2% (n = 81) of the included children. However, 80.2% (n = 65/81) of these affected children did not present with fetal anomalies eligible for PES. CONCLUSIONS: Almost one-fifth of children with a monogenic condition included in this study could have received a diagnosis via modern PES, avoiding a diagnostic odyssey lasting almost 4 years. However, despite having a monogenic condition, over half of the children did not present with any structural anomalies in utero. This demonstrates the degree to which fetal imaging is limited in its ability to reassure parents of the absence of a fetal genetic syndrome. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Sonner S, Mckenna C, Flanagan C, et al. Obtaining a Diagnostic Yield via Scan findings prior to the introduction of SEquencing retrospectivelY (ODYSSEY): a cohort study. Ultrasound Obstet Gynecol. 2026. PMID: 42600089. doi:10.1002/uog.70318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。